Abstract
Problem
To investigate the association between the occurrence of uterine leiomyoma and two SNPs of the CYP 2A13 and CYP 1A1 genes.
Method of study
Prospective case control study with 132 women with clinically and surgically diagnosed uterine leiomyoma and 260 controls. Genotyping was performed by polymerase chain reaction (PCR) based amplification of CYP 2A13 and CYP 1A1 genes, and restriction fragment length polymorphism (RFLP) analysis.
Results
Comparing women with uterine leiomyoma and controls, we demonstrate statistical significant differences of allele frequency and genotype distribution for the CYP 1A1 polymorphism (P = 0.025 and P = 0.046, respectively). Furthermore, for the CYP 2A13 polymorphism we found a significant difference concerning allele frequency (P = 0.033). However, for the genotype distribution, only borderline significance was observed (P = 0.064).
Conclusions
The CYP 2A13 and CYP 1A1 SNPs are associated with uterine leiomyoma in a Caucasian population and may contribute to the understanding of the pathogenic mechanisms of uterine leiomyoma.
Similar content being viewed by others
References
Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N et al (2004) Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 19(10):2350–2355
Sell SM, Tullis C, Stracner D, Song CY, Gewin J (2005) Minimal interval defined on 7q in uterine leiomyoma. Cancer Genet Cytogenet 157(1):67–69
Townsend DE, Sparkes RS, Baluda MC, McClelland G (1970) Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107(8):1168–1173
Wu J, Cheng Y (1995) [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations]. Zhonghua Fu Chan Ke Za Zhi 30(10):603–607
Jakimiuk AJ, Bogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wrobel A et al (2004) Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril 82(Suppl 3):1244–1249
Shastry BS (2002) SNP alleles in human disease and evolution. J Hum Genet 47(11):561–566
Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ (2003) The role of genetic polymorphisms in environmental health. Environ Health Perspect 111(8):1055–1064
Evans WE, McLeod HL (2003) Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 348(6):538–549
Hemminki K, Forsti A, Lorenzo BJ (2005) Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events. J Carcinog 4(1):2
Stiborova M, Martinek V, Rydlova H, Koblas T, Hodek P (2005) Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett 220(2):145–154
Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM et al (2004) Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89(1):344–351
Warner M, Hellmold H, Magnusson M, Rylander T, Hedlund E, Gustafsson JA (1998) Extrahepatic cytochrome P450: role in in situ toxicity and cell-specific hormone sensitivity. Arch Toxicol Suppl 20:455–463
Sharp L, Cardy AH, Cotton SC, Little J (2004) CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am J Epidemiol 160(8):729–740
Hukkanen J, Mantyla M, Kangas L, Wirta P, Hakkola J, Paakki P et al (1998) Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium. Pharmacol Toxicol 82(2):93–97
Zhang X, Su T, Zhang QY, Gu J, Caggana M, Li H et al (2002) Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J Pharmacol Exp Ther 302(2):416–423
Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56(21):4965–4969
Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55(17):3757–3758
Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J (1997) Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18(12):2307–2311
Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y et al (2000) Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10(1):25–33
Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR et al (2001) Case–control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 10(3):209–216
Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, Perret C et al (2001) Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene–environment interactions. Int J Cancer 92(2):220–225
Chang BL, Zheng SL, Isaacs SD, Turner A, Hawkins GA, Wiley KE et al (2003) Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer 106(3):375–378
Hefler LA, Grimm C, Heinze G, Schneeberger C, Mueller MW, Muendlein A et al (2005) Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod 20(5):1422–1427
Amant F, Dorfling CM, de Brabanter J, Vandewalle J, Vergote I, Lindeque BG et al (2004) A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. Acta Obstet Gynecol Scand 83(3):234–239
Hadfield RM, Manek S, Nakago S, Mukherjee S, Weeks DE, Mardon HJ et al (1999) Absence of a relationship between endometriosis and the N314D polymorphism of galactose-1-phosphate uridyl transferase in a UK population. Mol Hum Reprod 5(10):990–993
Hadfield RM, Manek S, Weeks DE, Mardon HJ, Barlow DH, Kennedy SH (2001) Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod 7(11):1073–1078
Ishii K, Takakuwa K, Kashima K, Tamura M, Tanaka K (2003) Associations between patients with endometriosis and HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum Reprod 18(5):985–989
Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE et al (2001) Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Mol Hum Reprod 7(11):1079–1083
Ishii K, Takakuwa K, Mitsui T, Tanaka K (2002) Studies on the human leukocyte antigen-DR in patients with endometriosis: genotyping of HLA-DRB1 alleles. Hum Reprod 17(3):560–563
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herr, D., Bettendorf, H., Denschlag, D. et al. Cytochrome P2A13 and P1A1 gene polymorphisms are associated with the occurrence of uterine leiomyoma. Arch Gynecol Obstet 274, 367–371 (2006). https://doi.org/10.1007/s00404-006-0201-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-006-0201-8